Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which - Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
- Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
- Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
- Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.
|
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.
Author and Disclosure Information
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA
Author and Disclosure Information
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA
Author and Disclosure Information
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA
Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which - Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
- Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
- Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
- Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.
|
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.
Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which - Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
- Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
- Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
- Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.
|
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.
Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
